Excell Partners
Excell Partners is a venture capital fund that invests in high-tech, high-growth startups in New York State, with a focus on Upstate NY. The firm aims to generate top-quartile returns while supporting regional economic development by providing both investment capital and hands-on support to entrepreneurs. Excell Partners is affiliated with the University of Rochester and was established through a partnership with New York State Empire State Development in 2006.
Excell Partners
What We Do
Excell invests up to $1.5M per round in high-growth companies, with a typical investment being around $1M.
Excell provides access to an extensive network of professionals, corporate, university, and government entities throughout New York State.
Excell offers a long-term partnership, bringing commitment to help portfolio companies launch and grow to a successful exit.
Portfolio
Developing a rapid and label-free biological assay platform for measuring clinical and point-of-care samples.
#Medical Diagnostics
Specializes in high performance nanomaterial design and industrial scale manufacturing.
#Nanotechnology
Provides professional development solutions with a cloud-based SaaS Learning Content Management System.
#E-learning
Provides voice services solutions with a focus on cost-effective, feature-rich, enhanced next-generation services.
#Telecommunications
Developing advanced Computed Tomography Technology for breast imaging.
#Medical Imaging
World’s first over-the-phone in-call translator for both inbound and outbound calls.
#Telecommunications
Focuses on Bioelectrochemical system offerings for wastewater treatment applications.
#Environmental Technology
Provides an automatic pill dispensing device to improve patient compliance with drug regimens.
#Medical Devices
Developed a breakthrough production process for invisible electrical circuitry on transparent films.
#Manufacturing Technology
Develops breakthroughs in worker safety, strength, and endurance.
#Wearable Technology
Received $500,000 in convertible debt financing to support operations and advance product development.
#Biotechnology
Key People
Director of Investment and Finance
Chief Operating Officer